All (4)News (4)Transcripts (0)Press Releases (0)

News206 days ago

TransCode Therapeutics Declines Following Reverse Stock Split Announcement

TransCode Therapeutics shares are trading lower after the company announced a 1-for-28 reverse stock split to comply with Nasdaq minimum bid price requirements.

News207 days ago

TransCode Therapeutics Reports Positive Clinical Trial Progress

TransCode Therapeutics shares are trading higher after announcing progress in their Phase 1a clinical trial of TTX-MC138, showing no dose limiting toxicities in patients with metastatic cancer.

News218 days ago

TransCode Therapeutics Advances in Clinical Trials and Fundraising

TransCode Therapeutics shares are trading higher after the company announced initial dosing in its fourth cohort of a crucial Phase 1 clinical trial with TTX-MC138, along with closing a direct offering raising $10 million for product development.

News221 days ago

TransCode Faces Stock Pressure After Share Offering

TransCode Therapeutics shares are trading lower after announcing a registered direct offering of 10,250,000 shares, raising concerns over stock dilution.